Background: Under physiological conditions, proximal tubular phosphate reabsorption via NaPi-IIa (and NaPi-IIc) ensures the maintenance of phosphate homeostasis. Impairment of NaPi-IIa, encoded by SLC34A1, is associated with various overlapping clinical syndromes, including hypophosphatemic nephrolithiasis with osteoporosis, renal Fanconi’s syndrome with chronic kidney disease, and idiopathic infantile hypercalcemia and nephrocalcinosis. Methods: A patient was referred to our hospital due to hyponatremia, hyperkalemia, and hypophosphatemia, as well as persistent hypercalcemia after fluid therapy and sodium replacement. At admission to our hospital, potassium and sodium values were normal. After initiation of phosphorus therapy, hypokalemia and metabolic alkalosis were observed. Renal sonography showed bilateral medullary nephrocalcinosis. Analyses of the SLC34A1 gene were performed due to hypercalcemia and hypophosphatemia. Results: Gene analyses identified a novel homozygous c.682T>C (p.W228R) (p.Trp228Arg) mutation. There are no previous reports of patients with SLC34A1 gene mutations presenting with hypokalemia and metabolic alkalosis. Conclusion: Herein, we present a case of infantile hypercalcemia 2 with a very different phenotype from that of previously described patients. Our findings provide further evidence for the wide range of phenotypic heterogeneity associated with NaPi-IIa impairment.

1.
Samuel
HS
.
Infantile hypercalcaemia, nutritional rickets, and infantile scurvy in Great Britain: A British Paediatric Association report
.
BMJ
.
1964
Jun
;
1
(
5399
):
1659
61
.
[PubMed]
0007-1447
2.
Pronicka
E
,
Kulczycka
H
,
Lorenc
R
,
Prószyńska
K
,
Gradzka
J
,
Rowińska
E
.
Increased serum level of 1,25-dihydroxyvitamin D3 after parathyroid hormone in the normocalcemic phase of idiopathic hypercalcemia
.
J Pediatr
.
1988
Jun
;
112
(
6
):
930
3
.
[PubMed]
0022-3476
3.
Misselwitz
J
,
Hesse
V
,
Markestad
T
.
Nephrocalcinosis, hypercalciuria and elevated serum levels of 1,25-dihydroxyvitamin D in children. Possible link to vitamin D toxicity
.
Acta Paediatr Scand
.
1990
Jun-Jul
;
79
(
6-7
):
637
43
.
[PubMed]
0001-656X
4.
Schlingmann
KP
,
Kaufmann
M
,
Weber
S
,
Irwin
A
,
Goos
C
,
John
U
, et al.
.
Mutations in CYP24A1 and idiopathic infantile hypercalcemia
.
N Engl J Med
.
2011
Aug
;
365
(
5
):
410
21
.
[PubMed]
0028-4793
5.
Rajagopal
A
,
Braslavsky
D
,
Lu
JT
,
Kleppe
S
,
Clément
F
,
Cassinelli
H
, et al.
.
Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis
.
J Clin Endocrinol Metab
.
2014
Nov
;
99
(
11
):
E2451
6
.
[PubMed]
0021-972X
6.
Schlingmann
KP
,
Ruminska
J
,
Kaufmann
M
,
Dursun
I
,
Patti
M
,
Kranz
B
, et al.
.
Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia
.
J Am Soc Nephrol
.
2016
Feb
;
27
(
2
):
604
14
.
[PubMed]
1046-6673
7.
Pronicka
E
,
Ciara
E
,
Halat
P
,
Janiec
A
,
Wójcik
M
,
Rowińska
E
, et al.
.
Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases
.
J Appl Genet
.
2017
Aug
;
58
(
3
):
349
53
.
[PubMed]
1234-1983
8.
Demir
K
,
Yildiz
M
,
Bahat
H
,
Goldman
M
,
Hassan
N
,
Tzur
S
, et al.
.
Clinical heterogeneity and phenotypic expansion of NaPi-IIa-associated disease
.
J Clin Endocrinol Metab
.
2017
Dec
;
102
(
12
):
4604
14
.
[PubMed]
0021-972X
9.
San Lucas
FA
,
Wang
G
,
Scheet
P
,
Peng
B
.
Integrated annotation and analysis of genetic variants from next-generation sequencing studies with variant tools
.
Bioinformatics
.
2012
Feb
;
28
(
3
):
421
2
.
[PubMed]
1367-4803
10.
National Heart, Lung, and Blood Institute
. NHLBI Exome Sequencing Project (ESP) Exome Variant Serve.
2017
. http://evs.gs.washington.edu./EVS/
11.
Wagner
CA
,
Hernando
N
,
Forster
IC
,
Biber
J
.
The SLC34 family of sodium-dependent phosphate transporters
.
Pflugers Arch
.
2014
Jan
;
466
(
1
):
139
53
.
[PubMed]
0031-6768
12.
Perwad
F
,
Azam
N
,
Zhang
MY
,
Yamashita
T
,
Tenenhouse
HS
,
Portale
AA
.
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice
.
Endocrinology
.
2005
Dec
;
146
(
12
):
5358
64
.
[PubMed]
0013-7227
13.
Antoniucci
DM
,
Yamashita
T
,
Portale
AA
.
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
.
J Clin Endocrinol Metab
.
2006
Aug
;
91
(
8
):
3144
9
.
[PubMed]
0021-972X
14.
Santoro
D
,
Caccamo
D
,
Lucisano
S
,
Buemi
M
,
Sebekova
K
,
Teta
D
, et al.
.
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system
.
BioMed Res Int
.
2015
;
2015
:
145828
.
[PubMed]
2314-6133
15.
Vaidya
A
,
Brown
JM
,
Williams
JS
.
The renin-angiotensin-aldosterone system and calcium-regulatory hormones
.
J Hum Hypertens
.
2015
Sep
;
29
(
9
):
515
21
.
[PubMed]
0950-9240
16.
Li
YC
,
Kong
J
,
Wei
M
,
Chen
ZF
,
Liu
SQ
,
Cao
LP
.
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
.
J Clin Invest
.
2002
Jul
;
110
(
2
):
229
38
.
[PubMed]
0021-9738
17.
Yuan
W
,
Pan
W
,
Kong
J
,
Zheng
W
,
Szeto
FL
,
Wong
KE
, et al.
.
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter
.
J Biol Chem
.
2007
Oct
;
282
(
41
):
29821
30
.
[PubMed]
0021-9258
You do not currently have access to this content.